Registration

THE DUBERSTEIN GROUP INC. for SANOFI-AVENTIS U.S. INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Copyright/Patent/Trademark CPT

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Health Issues HCR

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Medicare/Medicaid MMM

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Budget/Appropriations BUD

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Chemicals/Chemical Industry CHM

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Animals ANI

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Medical/Disease Research/Clinical Labs MED

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Advertising ADV

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; manufacturer pricing or rebate obligations and patient access under government programs, such as Medicaid and Medicare; animals in research; military & veterans healthcare programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
MICHAEL BERMAN New —
STEVEN CHAMPLIN New —
KENNETH DUBERSTEIN New —
BRIAN GRIFFIN New Sr. Ldrship Advisor, Sen. Dorgan
ERIC UELAND New PressSec/Economist/Policy&CommunicationsDir.Sen.Rep.PolicyComm;DCOS/COS,Sen.Asst.MajLdCOS, Sen.RulesComm; TransitionStaff,Sen.Maj.Ldr; AsstCOS/COS, Sen.Maj.Ldr.

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
SANOFI-AVENTIS SA France France 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.